BAPEN Symposium 4 on 'Managing complications in long-term parenteral nutrition': Managing liver dysfunction in parenteral nutrition

Proceedings of the Nutrition Society

Volumn 66, Issue 4, 2007, Pages 530-538

  Lloyd, David A J ^a   Gabe, Simon M ^a,b  

^a ST MARK S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cholestasis; Home parenteral nutrition; Liver disease; Parenteral nutrition

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; CHOLECYSTOKININ; CHOLINE; GENTAMICIN; GLUCOSE; LIPID; METRONIDAZOLE; TAURINE; URSODEOXYCHOLIC ACID; ANTIINFECTIVE AGENT;

ANATOMY; CHOLELITHIASIS; CHOLESTASIS; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFECT; ENTERIC FEEDING; GROUPS BY AGE; HUMAN; INCIDENCE; INTESTINE TRANSPLANTATION; KIDNEY FAILURE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; NEWBORN CARE; NUTRIENT CONTENT; NUTRITIONAL DEFICIENCY; OVERNUTRITION; PARENTERAL NUTRITION; PATHOGENESIS; PATIENT REFERRAL; SEPSIS; TREATMENT DURATION; TREATMENT INDICATION; LIVER DISEASE; REVIEW; RISK FACTOR;

BACTERIA (MICROORGANISMS);

ANTI-BACTERIAL AGENTS; CHOLESTASIS; ENTERAL NUTRITION; HUMANS; LIVER DISEASES; PARENTERAL NUTRITION; RISK FACTORS; SEPSIS; URSODEOXYCHOLIC ACID;

EID: 35548938691     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S002966510700585X     Document Type: Conference Paper

References (89)

1. Peden VH, Witzleben CL & Skelton MA (1971) Total parenteral nutrition. J Pediatr 78, 180-181.
2. Lindor KD, Fleming CR, Abrams A & Hirschkorn MA (1979) Liver function values in adults receiving total parenteral nutrition. JAMA 241, 2398-2400.
3. Clarke PJ, Ball MJ & Kettlewell MG (1991) Liver function tests in patients receiving parenteral nutrition. J Parenter Enteral Nutr 15, 54-59.
4. Quigley EM, Marsh MN, Shaffer JL & Markin RS (1993) Hepatobiliary complications of total parenteral nutrition. Gastroenterology 104, 286-301.
5. Wolfe BM, Walker BK, Shaul DB, Wong L & Ruebner BH (1988) Effect of total parenteral nutrition on hepatic histology. Arch Surg 123, 1084-1090.
6. Luman W & Shaffer JL (2002) Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr 21, 337-343.
7. Salvino R, Ghanta R, Seidner DL, Mascha E, Xu Y & Steiger E (2006) Liver failure is uncommon in adults receiving long-term parenteral nutrition. J Parenter Enteral Nutr 30, 202-208.
8. Ito Y & Shils ME (1991) Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection. J Parenter Enteral Nutr 15, 271-276.
9. Chan S, McCowen KC, Bistrian BR, Thibault A, Keane-Ellison M, Forse RA, Babineau T & Burke P (1999) Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 126, 28-34.
10. Cavicchi M, Beau P, Crenn P, Degott C & Messing B (2000) Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132, 525-532.
11. Sheldon GF, Peterson SR & Sanders R (1978) Hepatic dysfunction during hyperalimentation. Arch Surg 113, 504-508.
12. Watkins JB, Szczepanik P, Gould JB, Klein P & Lester R (1975) Bile salt metabolism in the human premature infant. Preliminary observations of pool size and synthesis rate following prenatal administration of dexamethasone and phenobarbital. Gastroenterology 69, 706-713.
13. Beale EF, Nelson RM, Bucciarelli RL, Donnelly WH & Eitzman DV (1979) Intrahepatic cholestasis associated with parenteral nutrition in premature infants. Pediatrics 64, 342-347.
14. Beath SV, Davies P, Papadopoulou A, Khan AR, Buick RG, Corkery JJ, Gornall P & Booth IW (1996) Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 31, 604-606.
15. Sondheimer JM, Asturias E & Cadnapaphornchai M (1998) Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 27, 131-137.
16. Nightingale JM (2003) Hepatobiliary, renal and bone complications of intestinal failure. Best Pract Res Clin Gastroenterol 17, 907-929.
17. Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K & Snelling AM (2007) Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin Nutr 26, 208-215.
18. Pappo I, Bercovier H, Berry E, Gallilly R, Feigin E & Freund HR (1995) Antitumor necrosis factor antibodies reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat. J Parenter Enteral Nutr 19, 80-82.
19. Buchman AL, Iyer K & Fryer J (2006) Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation. Hepatology 43, 9-19.
20. Langrehr JM, Reilly MJ, Banner B, Warty VJ, Lee KK & Schraut WH (1991) Hepatic steatosis due to total parenteral nutrition: the influence of short-gut syndrome, refeeding, and small bowel transplantation. J Surg Res 50, 335-343.
21. Lauro A, Zanfi C, Ercolani G et al. (2006) Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. Transplant Proc 38, 3620-3624.
22. Greenberg GR, Wolman SL, Christofides ND, Bloom SR & Jeejeebhoy KN (1981) Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 80, 988-993.
23. Alpers DH (2002) Enteral feeding and gut atrophy. Curr Opin Clin Nutr Metab Care 5, 679-683.
24. Hernandez G, Velasco N, Wainstein C, Castillo L, Bugedo G, Maiz A, Lopez F, Guzman S & Vargas C (1999) Gut mucosal atrophy after a short enteral fasting period in critically ill patients. J Crit Care 14, 73-77.
25. Sedman PC, MacFie J, Palmer MD, Mitchell CJ & Sagar PM (1995) Preoperative total parenteral nutrition is not associated with mucosal atrophy or bacterial translocation in humans. Br J Surg 82, 1663-1667.
26. Cook GC & Hutt MS (1967) The liver after kwashiokor. Br Med J 3, 454-457.
27. Richardson TJ & Sgoutas D (1975) Essential fatty acid deficiency in four adult patients during total parenteral nutrition. Am J Clin Nutr 28, 258-263.
28. Vina J, Vento M, Garcia-Sala F, Puertes IR, Gasco E, Sastre J, Asensi M & Pallardo FV (1995) L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 61, 1067-1069.
29. Chawla RK, Berry CJ, Kutner MH & Rudman D (1985) Plasma concentrations of transsulfuration pathway products during nasoenteral and intravenous hyperalimentation of malnourished patients. Am J Clin Nutr 42, 577-584.
30. Bowyer BA, Fleming CR, Ilstrup D, Nelson J, Reek S & Burnes J (1986) Plasma carnitine levels in patients receiving home parenteral nutrition. Am J Clin Nutr 43, 85-91.
31. Moukarzel AA, Dahlstrom KA, Buchman AL & Ament ME (1992) Carnitine status of children receiving long-term total parenteral nutrition: a longitudinal prospective study. J Pediatr 120, 759-762.
32. Buchman AL (2003) Choline deficiency during parenteral nutrition in humans. Nutr Clin Pract 18, 353-358.
33. Vinton NE, Laidlaw SA, Ament ME & Kopple JD (1987) Taurine concentrations in plasma, blood cells, and urine of children undergoing long-term total parenteral nutrition. Pediatr Res 21, 399-403.
34. Vinton NE, Laidlaw SA, Ament ME & Kopple JD (1986) Taurine concentrations in plasma and blood cells of patients undergoing long-term parenteral nutrition. Am J Clin Nutr 44, 398-404.
35. Karpati G, Carpenter S, Engel AG, Watters G, Allen J, Rothman S, Klassen G & Mamer OA (1975) The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology 25, 16-24.
36. Berner YN, Larchian WA, Lowry SF, Nicroa RR, Brennan MF & Shike M (1990) Low plasma carnitine in patients on prolonged total parenteral nutrition: association with low plasma lysine. J Parenter Enteral Nutr 14, 255-258.
37. Bowyer BA, Miles JM, Haymond MW & Fleming CR (1988) L-carnitine therapy in home parenteral nutrition patients with abnormal liver tests and low plasma carnitine concentrations. Gastroenterology 94, 434-438.
38. Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K & Ament ME (1993) Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 12, 33-37.
39. Buchman AL, Sohel M, Moukarzel A et al. (2001) Plasma choline in normal newborns, infants, toddlers, and in verylow-birth-weight neonates requiring total parenteral nutrition. Nutrition 17, 18-21.
40. Buchman AL, Dubin M, Jenden D, Moukarzel A, Roch MH, Rice K, Gornbein J, Ament ME & Eckhert CD (1992) Lecithin increases plasma free choline and decreases hepatic steatosis in long-term total parenteral nutrition patients. Gastroenterology 102, 1363-1370.
41. Buchman AL, Ament ME, Sohel M, Dubin M, Jenden DJ, Roch M, Pownall H, Farley W, Awal M & Ahn C (2001) Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. J Parenter Enteral Nutr 25, 260-268.
42. Belli DC, Roy CC, Fournier LA, Tuchweber B, Giguere R & Yousef IM (1991) The effect of taurine on the cholestatic potential of sulfated lithocholate and its conjugates. Liver 11, 162-169.
43. Dorvil NP, Yousef IM, Tuchweber B & Roy CC (1983) Taurine prevents cholestasis induced by lithocholic acid sulfate in guinea pigs. Am J Clin Nutr 37, 221-232.
44. Cooper A, Betts JM, Pereira GR & Ziegler MM (1984) Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition. J Pediatr Surg 19, 462-466.
45. Heird WC, Dell RB, Helms RA, Greene HL, Ament ME, Karna P & Storm MC (1987) Amino acid mixture designed to maintain normal plasma amino acid patterns in infants and children requiring parenteral nutrition. Pediatrics 80, 401-408.
46. Spencer AU, Yu S, Tracy TF et al. (2005) Parenteral nutrition-associated cholestasis in neonates: multivariate analysis of the potential protective effect of taurine. J Parenter Enteral Nutr 29, 337-343.
47. Schneider SM, Joly F, Gehrardt MF, Badran AM, Myara A, Thuillier F, Coudray-Lucas C, Cynober L, Trivin F & Messing B (2006) Taurine status and response to intravenous taurine supplementation in adults with short-bowel syndrome undergoing long-term parenteral nutrition: a pilot study. Br J Nutr 96, 365-370.
48. Hong L, Wu J & Cai W (2007) Glutathione decreased parenteral nutrition-induced hepatocyte injury in infant rabbits. J Parenter Enteral Nutr 31, 199-204.
49. Schepens MA, Roelofs HM, Peters WH & Wanten GJ (2006) No evidence for oxidative stress in patients on home parenteral nutrition. Clin Nutr 25, 939-948.
50. Lavoie JC, Chessex P, Gauthier C, Levy E, Alvarez F, St-Louis P & Rouleau T (2005) Reduced bile flow associated with parenteral nutrition is independent of oxidant load and parenteral multivitamins. J Pediatr Gastroenterol Nutr 41, 108-114.
51. Burke JF, Wolfe RR, Mullany CJ, Mathews DE & Bier DM (1979) Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake. Ann Surg 190, 274-285.
52. Li S, Nussbaum MS, Teague D, Gapen CL, Dayal R & Fischer JE (1988) Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats. J Surg Res 44, 639-648.
53. Hwang TL, Lue MC & Chen LL (2000) Early use of cyclic TPN prevents further deterioration of liver functions for the TPN patients with impaired liver function. Hepatogastroenterology 47, 1347-1350.
54. Guglielmi FW, Boggio-Bertinet D, Federico A et al. (2006) Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis 38, 623-642.
55. Li SJ, Nussbaum MS, McFadden DW, Gapen CL, Dayal R & Fischer JE (1988) Addition of glucagon to total parenteral nutrition (TPN) prevents hepatic steatosis in rats. Surgery 104, 350-357.
56. Meguid MM, Akahoshi MP, Jeffers S, Hayashi RJ & Hammond WG (1984) Amelioration of metabolic complications of conventional total parenteral nutrition. A prospective randomized study. Arch Surg 119, 1294-1298.
57. Bigorgne C, Le Tourneau A, Messing B, Rio B, Giraud V, Molina T, Audouin J & Diebold J (1996) Sea-blue histiocyte syndrome in bone marrow secondary to total parenteral nutrition including fat-emulsion sources: a clinicopathologic study of seven cases. Br J Haematol 95, 258-262.
58. Clayton PT, Whitfield P & Iyer K (1998) The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14, 158-164.
59. Clayton PT, Bowron A, Mills KA, Massoud A, Casteels M & Milla PJ (1993) Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease. Gastroenterology 105, 1806-1813.
60. Carpentier YA, Richelle M, Haumont D & Deckelbaum RJ (1990) New developments in fat emulsions. Proc Nutr Soc 49, 375-380.
61. Reimund JM, Arondel Y, Joly F, Messing B, Duclos B & Baumann R (2004) Potential usefulness of olive oilbased lipid emulsions in selected situations of home parenteral nutrition-associated liver disease. Clin Nutr 23, 1418-1425.
62. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR & Puder M (2006) Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics 118, e197-e201.
63. Vileisis RA, Inwood RJ & Hunt CE (1980) Prospective controlled study of parenteral nutrition-associated cholestatic jaundice: effect of protein intake. J Pediatr 96, 893-897.
64. Klein GL (1991) The aluminum content of parenteral solutions: current status. Nutr Rev 49, 74-79.
65. Fell JM, Reynolds AP, Meadows N, Khan K, Long SG, Quaghebeur G, Taylor WJ & Milla PJ (1996) Manganese toxicity in children receiving long-term parenteral nutrition. Lancet 347, 1218-1221.
66. Blaszyk H, Wild PJ, Oliveira A, Kelly DG & Burgart LJ (2005) Hepatic copper in patients receiving long-term total parenteral nutrition. J Clin Gastroenterol 39, 318-320.
67. Kennedy JF & Nightingale JM (2005) Cost savings of an adult hospital nutrition support team. Nutrition 21, 1127-1133.
68. Beath SV, Booth IW, Murphy MS, Buckels JA, Mayer AD, McKiernan PJ & Kelly DA (1995) Nutritional care and candidates for small bowel transplantation. Arch Dis Child 73, 348-350.
69. Spurr SG, Grylack LJ & Mehta NR (1989) Hyperalimentation-associated neonatal cholestasis: effect of oral gentamicin. J Parenter Enteral Nutr 13, 633-636.
70. Kubota A, Okada A, Imura K, Kawahara H, Nezu R, Kamata S & Takagi Y (1990) The effect of metronidazole on TPN-associated liver dysfunction in neonates. J Pediatr Surg 25, 618-621.
71. Capron JP, Gineston JL, Herve MA & Braillon A (1983) Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet i, 446-447.
72. Messing B, Bories C, Kunstlinger F & Bernier JJ (1983) Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology 84, 1012-1019.
73. Nightingale JM, Lennard-Jones JE, Gertner DJ, Wood SR & Bartram CI (1992) Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut 33, 1493-1497.
74. Buchman AL, Scolapio JS & Fryer JP (2003) American Gastroenterological Association technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 124, 1111-1134.
75. National Institute for Health and Clinical Excellence (2006) Nutrition Support in Adults: Oral Nutrition Support, Enteral Tube Feeding and Parenteral Nutrition. NICE Clinical Guideline 32. London: NICE.
76. Wallis K, Lloyd DA & Gabe SM (2007) Promoting intestinal adaptation. Br J Hosp Med 68, 11-14.
77. Food and Agriculture Organization/World Health Organization/ United Nations University (1993) Fats and Oils in Human Nutrition. Report of a Joint Expert Consultation. FAO Food and Nutrition Paper no. 57. Geneva: WHO.
78. Chan S, McCowen KC & Bistrian B (1998) Medium-chain triglyceride and n-3 polyunsaturated fatty acid-containing emulsions in intravenous nutrition. Curr Opin Clin Nutr Metab Care 1, 163-169.
79. Vahedi K, Atlan P, Joly F, Le Brun A, Evard D, Perennec V, Roux-Haguenau D, Bereziat G & Messing B (2005) A 3-month double-blind randomised study comparing an olive oil- with a soyabean oil-based intravenous lipid emulsion in home parenteral nutrition patients. Br J Nutr 94, 909-916.
80. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS & Chang MH (2004) Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. J Pediatr 145, 317-321.
81. De Marco G, Sordino D, Bruzzese E, Di Caro S, Mambretti D, Tramontano A, Colombo C, Simoni P & Guarino A (2006) Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther 24, 387-394.
82. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J & Sirotta L (1999) Parenteral nutrition-associated cholestasis in preterm neonates: Evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 12, 549-553.
83. Spagnuolo MI, Iorio R, Vegnente A & Guarino A (1996) Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology 111, 716-719.
84. Beau P, Labat-Labourdette J, Ingrand P & Beauchant M (1994) Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 20, 240-244.
85. Howard L & Ashley C (2003) Management of complications in patients receiving home parenteral nutrition. Gastroenterology 124, 1651-1661.
86. Buchman AL, Dubin MD, Moukarzel AA, Jenden DJ, Roch M, Rice KM, Gornbein J & Ament ME (1995) Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 22, 1399-1403.
87. Misra S, Ahn C, Ament ME, Choi HJ, Jenden DJ, Roch M & Buchman AL (1999) Plasma choline concentrations in children requiring long-term home parenteral nutrition: a case control study. J Parenter Enteral Nutr 23, 305-308.
88. Grant D, Abu-Elmagd K, Reyes J, Tzakis A, Langnas A, Fishbein T, Goulet O & Farmer D (2005) 2003 report of the intestine transplant registry: a new era has dawned. Ann Surg 241, 607-613.
89. Middleton SJ & Jamieson NV (2005) The current status of small bowel transplantation in the UK and internationally. Gut 54, 1650-1657.